Table 5 Comparison of general information and gene expressions between patients with and without epilepsy

Gender[cases (%)]

 Male

2(50.00)

14(66.67)

0.405

0.524

 Female

2(50.00)

7(33.33)

Age (\(\overline{x} \pm {\text{s}}\), years old)

68.00 ± 3.56

70.29 ± 4.71

0.915

0.370

Smoking history[cases (%)]

 Yes

2(50.00)

12(57.14)

0.070

0.792

 No

2(50.00)

9(42.86)

Systolic pressures (\(\overline{x} \pm {\text{s}}\), mmHg)

180.00 ± 6.98

176.67 ± 11.75

0.554

0.592

Diastolic pressures (\(\overline{x} \pm {\text{s}}\), mmHg)

98.25 ± 12.82

99.86 ± 13.31

0.222

0.826

Diabetes[cases (%)]

2(50.00)

11(52.38)

0.008

0.930

Hyperlipidemia[cases (%)]

2(50.00)

9(42.86)

0.070

0.792

Coronary heart disease[cases (%)]

0(0.00)

3(14.29)

0.649

0.420

Hypertension course (\(\overline{x} \pm {\text{s}}\), years)

11.50 ± 2.38

11.95 ± 3.22

0.266

0.793

Cerebral hemorrhage volume (\(\overline{x} \pm {\text{s}}\), ml)

54.25 ± 16.40

46.71 ± 10.11

1.241

0.227

Gene expressions

 SPI1

0.66 ± 0.08

0.51 ± 0.10

3.462

0.002

 HK3

1.62 ± 0.10

1.45 ± 0.27

1.243

0.226

 HCK

1.61 ± 0.12

1.43 ± 0.18

1.847

0.078

 SYK

1.61 ± 0.11

1.46 ± 0.18

1.625

0.118

 CD14

1.60 ± 0.11

1.45 ± 0.19

1.538

0.138

 FCER1G

1.64 ± 0.17

1.81 ± 0.10

1.768

0.090

 CYBB

1.60 ± 0.10

1.39 ± 0.20

1.962

0.062

 FGR

1.71 ± 0.13

1.52 ± 0.19

1.921

0.067